anti-Hantavirus, nucleoprotein antibody product blog
Tags: Antibody; Monoclonal Antibody; Hantavirus, nucleoprotein; anti-Hantavirus, nucleoprotein antibody;
The Hantavirus, nucleoprotein n/a (Catalog #MBS602105) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Hantavirus, nucleoprotein can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Optimal dilutions to be determined by the researcher. Researchers should empirically determine the suitability of the Hantavirus, nucleoprotein n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The members of the Hantavirus genus of the family Bunyaviridae are spherical, enveloped viruses containing tripartite negative-sense RNA as their genome. The three genomic RNA segments, designated L, M, and S, encode an RNA-dependent RNA polymerase, envelope glycoproteins (G1 and G2), and nucleocapsid (N) protein, respectively. Hantavirus infections can cause two serious and often fatal human diseases, hemorrhagic fever with renal syndrome and hantaviral pulmonary syndrome, characterized by lung damage and cardiac dysfunction. Humans are infected with Hantaviruses from rodent reservoirs that are persistently infected without signs of disease.
Immunogen: Synthetic peptide corresponding to nucleoprotein aa58-87 of Andes virus glycoprotein. Grade: Affinity Purified. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Hantavirus, nucleoprotein are readily searchable from our website. Different antibodies against the same target such as Hantavirus, nucleoprotein may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.